Myriad Genetics sell Bank of America Co.
Start price
03.03.25
/
50%
€10.30
Target price
03.03.26
€10.50
Performance (%)
-53.98%
Price
30.01.26
€4.54
Summary
This prediction is currently active. The SELL prediction by Bank_of_America_Co_ for Myriad Genetics is performing very well with a performance of -53.98%. This prediction currently runs until 03.03.26. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Myriad Genetics | -8.097% | -8.097% |
| iShares Core DAX® | -1.432% | 0.000% |
| iShares Nasdaq 100 | -0.386% | -0.595% |
| iShares Nikkei 225® | 1.448% | 5.269% |
| iShares S&P 500 | 0.114% | -0.217% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Myriad Genetics diskutieren
Myriad Genetics, Inc. (NASDAQ: MYGN) had its price target lowered by analysts at Bank of America Co. from $13.00 to $11.00. They now have an "underperform" rating on the stock.
Ratings data for MYGN provided by MarketBeat